Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2020 / N 1

Эффективность креатинфосфата в составе комплексной терапии у больных с хронической сердечной недостаточностью, перенесших инфаркт миокарда с подъемом сегмента ST
В.П. Михин, Т.А. Николенко, Н.И. Громнацкий

Список литературы

1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007 Sep;93(9):1137-46.
2. Поляков Д.С., Фомин И.В., Валикулова Ф.Ю., Вайсберг А.Р., Краием Н., Бадин Ю.В., Щербинина Е.В., Иванченко Е.Ю. Эпидемиологическая программа ЭПОХА–ХСН: декомпенсация хронической сердечной недостаточности в реальной клинической практике (ЭПОХА–Д–ХСН). Журнал Сердечная недостаточность 2016;17(5):299-305.
3. van Riet EES, Hoes AW, Limburg A, Landman MAJ, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. European Journal of Heart Failure 2014 Jul;16(7):772-7.
4. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал 2016;21(8):7-13.
5. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VR. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Internal Medicine 2015 Јun;175(6):996-1004.
6. Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet 2003 Sep;362(9386):782-8.
7. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. European Heart Journal 2012 Jun;33(14):1750-7.
8. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme – a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis. European Heart Journal 2003 Mar;24(5):442-63.
9. Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. Annual Review of Biochemistry 1985;54:831-62.
10. Post JA, Langer GA, Op den Kamp JA, Verkleij AJ. Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and ‘gas-dissected’ membranes. Biochimica et Biophysica Acta 1988 Aug;943(2):256-66.
11. Zhang W, Zhang H, Xing Y. Protective effects of phosphocreatine administered post- treatment combined with ischemic post-conditioning on rat hearts with myocardial ischemia/reperfusion injury. Journal of Clinical Medicine Research 2015 Apr;7(4):242-7.
12. Azova MM, Blagonravov ML, Frolov VA. Effect of phosphocreatine and ethylmethylhydroxypyridine succinate on the expression of Bax and Bcl-2 proteins in left-ventricular cardiomyocytes of spontaneously hypertensive rats. Bulletin of Experimental Biology and Medicine 2015 Jan;158(3):313-4.
13. Fang MX, Landoni G, Zangrillo A, Monaco F, Lomivorotov VV, Hui C, Novikov M, Nepomniashchikh N, Fominskiy E. Phosphocreatine in cardiac surgery patients: a meta-analysis of randomized controlled trials. Journal of Cardiothoracic and Vascular Anesthesia 2018 Apr;32(2):762-70.
14. Deng KW, Shi XB, Zhao YX, Yang SW, Zhou YJ, Shi DM, Liu YY, Jia DA, Fang Z, Zhou ZM, Ge HL, Yan ZX, Ma CS. The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention. Angiology 2015 Feb;66(2):163-8.
15. Cisowski M, Bochenek A, Kucewicz E, Wnuk-Wojnar AM, Morawski W, Skalski J, Grzybek H. The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery. The Journal of Cardiovascular Surgery (Torino) 1996 Dec;37(6 Suppl 1):75-80.
16. Хапий Х.Х., Филипповская Ж.С., Хапий И.Х., Лопатин А.Ф. Оценка эффективности применения неотона в послеоперационном периоде. Вестник интенсивной терапии 2011;4:34-7.
17. Barayev OV, Zotov AS, Ilyin MV, Smirnova VP, Tsybin NV. Results of exogenous phosphocreatine use in coronary artery bypass surgery using extracorporeal circulation system in patients with reduced myocardial flow reserves. Bulletin of Pirogov National Medical & Surgical Center 2012;7(4):25-8.
18. Andreev N, Andreva T, Bichkov I. Effect of phosphocreatine in congestive heart failure. Current Therapeutic Research 1992;51:649-60.
19. Wang FR, Zheng X. Effects of phosphocreatine on plasma brain natriuretic peptide level and left ventricular function in patients with heart failure. PJCCPVD 2008;16:29-31.
20. Ying W, Yuli C, Ying W. GW24-e0780 efficiency of creatine phosphate sodium and hyzaar in hypertensive patients with diastolic dysfunction. Heart 2013 Oct;99(Suppl 3):A222.
21. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Беграмбекова Ю.Л., Васюк Ю.А., Гарганеева А.А., Гендлин Г.Е., Глезер М.Г., Готье С.В., Довженко Т.В., Кобалава Ж.Д., Козиолова Н.А., Коротеев А.В., Мареев Ю.В., Овчинников А.Г., Перепеч Н.Б., Тарловская Е.И., Чесникова А.И., Шевченко А.О., Арутюнов Г.П., Беленков Ю.Н., Галявич А.С., Гиляревский С.Р., Драпкина О.М., Дупляков Д.В., Лопатин Ю.М., Ситникова М.Ю., Скибицкий В.В., Шляхто Е.В. Клинические рекомендации ОССН–РКО–РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология 2018;58(6S):8-164.
22. Руководство по ультразвуковой диагностике. Под ред. Митькова В.В. М.: Визир; 2007: 123-4.
23. Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы: реабилитация и вторичная профилактика. Российские клинические рекомендации. CardioСоматика 2014;S1:5-42.
24. Шахнович П.Г., Захарова А.И., Черкашин Д.В., Свистов А.С., Шуленин К.С., Ткаченко К.Н., Аланичев А.Е., Макиев Р.Г., Кутелев Г.Г., Ефимов С.В. Диастолическая дисфункция миокарда: эхокардиографический феномен или вид сердечной недостаточности? Вестник Российской военно-медицинской академии 2015;3(51):54-7.
25. Gaddi AV, Galuppo P, Yang J. Creatine phosphate administration in cell energy impairment conditions: a summary of past and present research. Heart, Lung & Circulation 2017 Oct;26(10):1026-35.

References

1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007 Sep;93(9):1137-46.
2. Polyakov DS, Fomin IV, Valikulova FYu, Vaysberg AR, Kraiem N, Badin YuV, Shcherbinina EV, Ivanchenko EYu. Epidemiological program EPOCH–CHF: decompensation of chronic heart failure in real clinical practice (EPOCH–D–CHF). Journal of Heart Failure 2016;17(5):299-305 (In Russian).
3. van Riet EES, Hoes AW, Limburg A, Landman MAJ, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. European Journal of Heart Failure 2014 Jul;16(7):772-7.
4. Fomin IV. Chronic heart failure in the Russian Federation: what we know today and what we should do. Russian Journal of Cardiology 2016;21(8):7-13 (In Russian).
5. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VR. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Internal Medicine 2015 Јun;175(6):996-1004.
6. Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet 2003 Sep;362(9386):782-8.
7. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. European Heart Journal 2012 Jun;33(14):1750-7.
8. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme – a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis. European Heart Journal 2003 Mar;24(5):442-63.
9. Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. Annual Review of Biochemistry 1985;54:831-62.
10. Post JA, Langer GA, Op den Kamp JA, Verkleij AJ. Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and ‘gas-dissected’ membranes. Biochimica et Biophysica Acta 1988 Aug;943(2):256-66.
11. Zhang W, Zhang H, Xing Y. Protective effects of phosphocreatine administered post- treatment combined with ischemic post-conditioning on rat hearts with myocardial ischemia/reperfusion injury. Journal of Clinical Medicine Research 2015 Apr;7(4):242-7.
12. Azova MM, Blagonravov ML, Frolov VA. Effect of phosphocreatine and ethylmethylhydroxypyridine succinate on the expression of Bax and Bcl-2 proteins in left-ventricular cardiomyocytes of spontaneously hypertensive rats. Bulletin of Experimental Biology and Medicine 2015 Jan;158(3):313-4.
13. Fang MX, Landoni G, Zangrillo A, Monaco F, Lomivorotov VV, Hui C, Novikov M, Nepomniashchikh N, Fominskiy E. Phosphocreatine in cardiac surgery patients: a meta-analysis of randomized controlled trials. Journal of Cardiothoracic and Vascular Anesthesia 2018 Apr;32(2):762-70.
14. Deng KW, Shi XB, Zhao YX, Yang SW, Zhou YJ, Shi DM, Liu YY, Jia DA, Fang Z, Zhou ZM, Ge HL, Yan ZX, Ma CS. The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention. Angiology 2015 Feb;66(2):163-8.
15. Cisowski M, Bochenek A, Kucewicz E, Wnuk-Wojnar AM, Morawski W, Skalski J, Grzybek H. The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery. The Journal of Cardiovascular Surgery (Torino) 1996 Dec;37(6 Suppl 1):75-80.
16. Khapiy KhKh, Filippovskaya ZhS, Khapiy IKh, Lopatin AF. Evaluating the efficacy of neoton in the postoperative period. Annals of Critical Care 2011;4:34-7 (In Russian).
17. Barayev OV, Zotov AS, Ilyin MV, Smirnova VP, Tsybin NV. Results of exogenous phosphocreatine use in coronary artery bypass surgery using extracorporeal circulation system in patients with reduced myocardial flow reserves. Bulletin of Pirogov National Medical & Surgical Center 2012;7(4):25-8.
18. Andreev N, Andreva T, Bichkov I. Effect of phosphocreatine in congestive heart failure. Current Therapeutic Research 1992;51:649-60.
19. Wang FR, Zheng X. Effects of phosphocreatine on plasma brain natriuretic peptide level and left ventricular function in patients with heart failure. PJCCPVD 2008;16:29-31.
20. Ying W, Yuli C, Ying W. GW24-e0780 efficiency of creatine phosphate sodium and hyzaar in hypertensive patients with diastolic dysfunction. Heart 2013 Oct;99(Suppl 3):A222.
21. Mareyev VYu, Fomin IV, Ageyev FT, Begrambekova YuL, Vasyuk YuA, Garganeyeva AA, Gendlin GE, Glezer MG, Gautier SV, Dovzhenko TV, Kobalava ZhD, Kosilova NA, Koroteyev AV, Mareyev YuV, Ovchinnikov AG, Perepech NB, Tarlovskaya EI, Chesnikova AI, Shevchenko AO, Arutyunov GP, Belenkov YuN, Galyavich AS, Gilyarevskiy SR, Drapkina OM, Duplyakov DV, Lopatin YuM, Sitnikova MYu, Skibitskiy VV, Shlyakhto EV. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia 2018;58(6S):8-164 (In Russian).
22. Guidelines of ultrasound diagnostics. Mitkov VV, editor. Moscow: Vizir; 2007: 123-4 (In Russian).
23. Acute myocardial infarction in patients with ST-segment elevation: rehabilitation and secondary prevention. Russian clinical guidelines. Cardiosomatics 2014;S1:5-42 (In Russian).
24. Shakhnovich PG, Zakharova AI, Cherkashin DV, Svistov AS, Shulenin KS, Tkachenko KN, Alanichev AE, Makiyev RG, Kutelev GG, Yefimov SV. Diastolic myocardial dysfunction: echocardiographic phenomenon or type of heart failure? Vestnik Rossiyskoi Voenno-Medicinskoi Academii 2015;3(51):54-7 (In Russian).
25. Gaddi AV, Galuppo P, Yang J. Creatine phosphate administration in cell energy impairment conditions: a summary of past and present research. Heart, Lung & Circulation 2017 Oct;26(10):1026-35.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]